Searched for
ALKEM LABORATORIES SHARES
Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block dealShares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece o...
Stocks in news: Alkem Labs, Vedanta, Canara Bank, NHPC, Adani PortsMarkets closed higher on weekly expiry day despite volatility, with Nifty showing signs of recovery but facing resistance around 23,800-24,...
Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyersAlkem Laboratories shares experienced significant block deals totaling Rs 930 crore. Promoter family entities divested shares to a group of...
Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
I-Sec maintains Add on Alkem Laboratories, revises target price to Rs 5,900ICICI Securities maintains an Add call on Alkem Laboratories, revising the target price to Rs 5,900. The brokerage anticipates a revenue CA...
Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold?Alkem Laboratories shares fell 5% after Q4FY25 results showed a modest 4.2% profit rise to Rs 306 crore and margin contraction to 12.4%. Wh...
Add Alkem Laboratories, target price Rs 5,700: HDFC SecuritiesHDFC Securities suggests adding Alkem Laboratories shares, targeting Rs 5,700. Alkem, a large pharmaceutical company, reported its financia...
Add Alkem Laboratories, target price Rs 6,180: HDFC SecuritiesHDFC Securities recommends buying shares of Alkem Laboratories. They set a target price of Rs 6,180. The current market price is Rs 5,535. ...
Alkem Labs to grow chronic therapies, biosimilars to drive future growth: MDAlkem Laboratories, a top-seller of antibiotics, is focusing on the chronic therapy segments and is investing heavily in biosimilars and co...
Buy Alkem Laboratories, target price Rs 3916: ICICI SecuritiesAlkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 33880.54 Crore) operating in Phar...
Buy Alkem Laboratories, target price Rs 3665: Motilal OswalAlkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 33677.87 Crore) operating in Phar...
Buy Alkem Laboratories, target price Rs 2,882: ICICI SecuritiesThe brokerage is positive on the long-term outlook given the sustainable growth in the domestic market and continued scale-up in US generic...
Buy Alkem Labs, target price Rs 2,897: Anand RathiAlkem’s Q4 FY20 sales growth is likely to be up 10 per cent to Rs 20 billion.
Adrenaline Rush: This drug firm is up 32% in 40 days, and is ready to rallyThe stock has been a darling of mutual funds and foreign institutional investors (FIIs).
Buy Alkem Laboratories, target Rs 2,050: Reliance SecuritiesBuy Alkem Laboratories Ltd. at a price target of Rs 2050.0 .
Alkem Laboratories Q4 net up 58% at Rs 136.96 croreThe company had posted a net profit of Rs 86.54 crore in the same period of the previous fiscal